These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4596819)

  • 1. [Determination of antibodies by immunofluorescence in sera of patients with recent cutaneous lesions of mucocutaneous American leishmaniasis].
    Chiari Cde A; Magalhães P; Mayrink W
    Rev Inst Med Trop Sao Paulo; 1973; 15(5):304-9. PubMed ID: 4596819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of circulating antibodies by the immunofluorescence method in cutaneous leishmaniasis].
    Bittencourt AL; Sodré A; Andrade ZA
    Rev Inst Med Trop Sao Paulo; 1968; 10(4):247-52. PubMed ID: 4878384
    [No Abstract]   [Full Text] [Related]  

  • 3. Parasitologic and immunologic diagnosis of American (mucocutaneous) leishmaniasis.
    Cuba Cuba CA; Marsden PD; Barreto AC; Rocha R; Sampaio RR; Patzlaff L
    Bull Pan Am Health Organ; 1981; 15(3):249-59. PubMed ID: 7030439
    [No Abstract]   [Full Text] [Related]  

  • 4. Borderline cutaneous leishmaniasis. Clinical, immunological and histological differences from mucocutaneous leishmaniasis.
    Moriearty PL; Bittencourt AL; Pereira C; Teixeira R; Barreto E; Guimarães NA
    Rev Inst Med Trop Sao Paulo; 1978; 20(1):15-21. PubMed ID: 418492
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.
    Valli LC; Passos VM; Dietze R; Callahan HL; Berman JD; Grogl M
    J Parasitol; 1999 Dec; 85(6):1076-83. PubMed ID: 10647040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indirect immunofluorescent reaction in the control and treatment of American cutaneous leishmaniasis].
    Chiari Cde A; Mayrink W; Magalhães PA
    Rev Inst Med Trop Sao Paulo; 1973; 15(5):298-303. PubMed ID: 4596818
    [No Abstract]   [Full Text] [Related]  

  • 7. [Detection of antibodies in cutaneous leishmaniasis].
    Dobrzhanskaia RS; Gusev AI
    Med Parazitol (Mosk); 1975; 44(4):411-6. PubMed ID: 809656
    [No Abstract]   [Full Text] [Related]  

  • 8. New world leishmaniasis. Serologic aids to diagnosis.
    Price SM; Silvers DN
    Arch Dermatol; 1977 Oct; 113(10):1415-6. PubMed ID: 334085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of chemotherapy of American leishmaniasis by the indirect fluorescent antibody test.
    Walton BC
    Am J Trop Med Hyg; 1980 Sep; 29(5):747-52. PubMed ID: 7001935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Racial composition and evaluation of the Montenegro cutaneous reaction in patients with mucocutaneous leishmaniasis].
    Tavares-Neto J; Costa JM; Marsden PD; Barreto AC; Cuba CC
    Rev Soc Bras Med Trop; 1986; 19(2):75-8. PubMed ID: 3432627
    [No Abstract]   [Full Text] [Related]  

  • 11. Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis.
    Rocha RA; Sampaio RN; Guerra M; Magalhâes A; Cuba CC; Barreto AC; Marsden PD
    J Trop Med Hyg; 1980 Aug; 83(4):131-9. PubMed ID: 6997505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of fluorescent antibody indirect reactions in Chagas' disease, mucocutaneous leishmaniasis and kala-azar using various Leishmania and Trypanosoma antigens].
    Nery-Guimarães F; Lage HA; Venancio IA; Grynberg NF
    Hospital (Rio J); 1969 May; 75(5):1811-25. PubMed ID: 4979318
    [No Abstract]   [Full Text] [Related]  

  • 13. [Visceral and cutaneous leishmaniasis].
    Aulepp H; Gartmann H; Steigleder GK
    Z Hautkr; 1975 May; 50(9):355-64. PubMed ID: 52950
    [No Abstract]   [Full Text] [Related]  

  • 14. [Demonstration of immunoglobulins (IgG) using the immunoflorescence technic in the basal membrane of epidermis in tuberculoid Leishmaniasis].
    Remy W; Bockendahl H
    Dermatol Monatsschr; 1972 Jul; 158(7):517-20. PubMed ID: 4559262
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating immune complexes and anti-IgG antibodies in mucocutaneous leishmaniasis.
    Desjeux P; Santoro F; Afchain D; Loyens M; Capron A
    Am J Trop Med Hyg; 1980 Mar; 29(2):195-8. PubMed ID: 7369437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A histological classification of mucocutaneous leishmaniasis in Brazil and its clinical evaluation.
    Ridley DS; Marsden PD; Cuba CC; Barreto AC
    Trans R Soc Trop Med Hyg; 1980; 74(4):508-14. PubMed ID: 7445048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eco-epidemiological survey of Leishmania (Viannia) braziliensis American cutaneous and mucocutaneous leishmaniasis in Ribeira Valley River, Paraná State, Brazil.
    de Castro EA; Luz E; Telles FQ; Pandey A; Biseto A; Dinaiski M; Sbalqueiro I; Soccol VT
    Acta Trop; 2005 Feb; 93(2):141-9. PubMed ID: 15652328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunofluorescence in mucocutaneous leishmaniasis].
    Azulay RD; Monteiro M; Vaz EM
    An Bras Dermatol; 1968; 43(1):76. PubMed ID: 4890672
    [No Abstract]   [Full Text] [Related]  

  • 19. American cutaneous leishmaniasis associated with HIV infection: report of four cases.
    Mattos M; Caiza A; Fernandes O; Gonçalves AJ; Pirmez C; Souza CS; Oliveira-Neto MP
    J Eur Acad Dermatol Venereol; 1998 May; 10(3):218-25. PubMed ID: 9643324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific immunodeficiency and its relation to the spectrum of American cutaneous leishmaniasis.
    Convit J; Ulrich M
    Biol Res; 1993; 26(1-2):159-66. PubMed ID: 7545499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.